YS Biopharma Co., Ltd. – NASDAQ:YS

Add to watchlist

$1.07

+0.05

+4.9%

Market closed

Open in 1 day

+13.52%

month

+150.12%

quarter

-20.93%

year

Market Cap	192.09M
Enterprise value	N/A

P/E	N/A
EV/Sales	N/A
EV/EBITDA	N/A
Price/Sales	N/A
Price/Book	N/A
PEG ratio	N/A
EPS	N/A

Revenue	N/A
EBITDA	N/A
Income	N/A
Revenue Q/Q	N/A
Revenue Y/Y	N/A

Profit margin	0%
Oper. margin	0%
Gross margin	0%
EBIT margin	0%
EBITDA margin	N/A

Get more financial ratios!

Every financial ratio you might need
10 years history
Forward ratios (Analysts estimates)

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

YS Biopharma Co., Ltd. (NASDAQ:YS): Profit margin
2023	687.20M	-145.47M	-21.17%

YS Biopharma Co., Ltd. Financials Estimate

Q Y

YS Biopharma Co., Ltd. (NASDAQ:YS): Analyst Estimates
2026	1.38B	118.44M	8.54%
2027	1.80B	431.60M	23.94%

Analysts Price target
Financials & Ratios estimates

YS Biopharma Co., Ltd. (NASDAQ:YS): Earnings per share (EPS)
2024-01-22	-0.72	-0.16

YS Biopharma Co., Ltd. (NASDAQ:YS): Debt to assets
Mar 2022	1441753141	2.14B	148.48%
Jun 2022	0	0
Sep 2022	1548438120	2.49B	161.4%
Mar 2023	1719753611	991.30M	57.64%

YS Biopharma Co., Ltd. (NASDAQ:YS): Cash Flow
Mar 2023	0	0	0

YS Biopharma Co., Ltd. alternative data

YS Biopharma Co., Ltd.
Employees

YS Biopharma Co., Ltd. (NASDAQ:YS): Employee count
Aug 2023	865
Sep 2023	773
Oct 2023	773
Nov 2023	773
Dec 2023	773
Jan 2024	773
Feb 2024	754
Mar 2024	754
Apr 2024	754
May 2024	773
Jun 2024	773
Jul 2024	773

YS Biopharma Co., Ltd.
Earnings Call Transcripts

Quarter	Transcript
Q3 2024 19 Apr 2024	Q3 2024 Earnings Call Transcript

YS earnings call transcripts

YS Biopharma Co., Ltd.
Latest News

Friday, 24 May 2024
07:30	YS Biopharma Announces Name Change to LakeShore Biopharma	prnewswire.com
Tuesday, 21 May 2024
16:15	YS Biopharma Announces Results of Extraordinary General Meeting	prnewswire.com
Tuesday, 7 May 2024
16:20	YS Biopharma to Hold Extraordinary General Meeting on May 21, 2024 and Announces the Appointment of Interim Chief Executive Officer	prnewswire.com
Monday, 29 April 2024
08:00	YS Biopharma Receives Additional 180 Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule	prnewswire.com
Friday, 19 April 2024
09:10	YS Biopharma Co., Ltd. (YS) Q3 2024 Earnings Call Transcript	Seeking Alpha
Tuesday, 19 December 2023
09:08	3 Penny Stocks That Are Too Compelling to Ignore	InvestorPlace
Friday, 25 August 2023
08:00	Why Is YS Biopharma (YS) Stock Up 71% Today?	InvestorPlace
07:59	Why Is YS Biopharma (YS) Stock Up 71% Today?	InvestorPlace
Friday, 21 July 2023
16:30	YS Biopharma to Report Financial Results for Fiscal Year 2023 on July 26, 2023	PRNewsWire
Tuesday, 13 June 2023
08:28	Why Is YS Biopharma (YS) Stock Up 31% Today?	InvestorPlace

Frequently Asked Questions (FAQ)

What's the price of YS Biopharma Co., Ltd. stock today?

One share of YS Biopharma Co., Ltd. stock can currently be purchased for approximately $1.07.
When is YS Biopharma Co., Ltd.'s next earnings date?

Unfortunately, YS Biopharma Co., Ltd.'s (YS) next earnings date is currently unknown.
Does YS Biopharma Co., Ltd. pay dividends?

No, YS Biopharma Co., Ltd. does not pay dividends.
How much money does YS Biopharma Co., Ltd. make?

YS Biopharma Co., Ltd. has a market capitalization of 192.09M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 36.63% to 687.2M US dollars. YS Biopharma Co., Ltd. made a loss 145.48M US dollars in net income (profit) last year or -$0.16 on an earnings per share basis.
What is YS Biopharma Co., Ltd.'s stock symbol?

YS Biopharma Co., Ltd. is traded on the NASDAQ under the ticker symbol "YS".
What is YS Biopharma Co., Ltd.'s primary industry?

Company operates in the Healthcare sector and Biotechnology industry.
How do i buy shares of YS Biopharma Co., Ltd.?

Shares of YS Biopharma Co., Ltd. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
How many employees does YS Biopharma Co., Ltd. have?

As Jul 2024, YS Biopharma Co., Ltd. employs 773 workers, which is 3% more then previous quarter.
When YS Biopharma Co., Ltd. went public?

YS Biopharma Co., Ltd. is publicly traded company for more then 4 years since IPO on 5 Aug 2021.
What is YS Biopharma Co., Ltd.'s official website?

The official website for YS Biopharma Co., Ltd. is yishengbio.com.
How can i contact YS Biopharma Co., Ltd.?

YS Biopharma Co., Ltd. can be reached via phone at +86 10 8920 2086.

YS Biopharma Co., Ltd.

yishengbio.com

Exchange:

NASDAQ

Full time employees:

773

Industry:

Biotechnology

Sector:

Healthcare

YS Biopharma Co., Ltd., a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. It develops a proprietary PIKA immunomodulating technology platform and a series of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, and Shingles. It operates in China, the United States, Singapore, the United Arab Emirates, and the Philippines. The company was founded in 2002 and is based in Beijing, China.

+86 10 8920 2086

Building No. 2
Beijing, 102600

CIK: 0001946399
ISIN: KYG9845F1090
: